# Effects of Lutein in Retinitis Pigmentosa

> **NCT00029289** · PHASE1,PHASE2 · COMPLETED · sponsor: **National Center for Complementary and Integrative Health (NCCIH)**

## Conditions studied

- Retinitis Pigmentosa

## Interventions

- **DRUG:** Lutein (10 or 30 mg/day) capsules

## Key facts

- **NCT ID:** NCT00029289
- **Lead sponsor:** National Center for Complementary and Integrative Health (NCCIH)
- **Sponsor class:** NIH
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-04
- **Primary completion:** —
- **Final completion:** 2002-10
- **Target enrollment:** — (—)
- **Last updated:** 2006-08-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00029289

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00029289, "Effects of Lutein in Retinitis Pigmentosa". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00029289. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*